About Global MediXchange for Combating COVID-19 (GMCC)

Sharing and cooperation is the best prescription to fight against the new unknown virus.

"Now, we can't beat this virus unless we share our resources, know-how and hard-earned lessons."

—Jack Ma, Founder of Jack Ma Foundation

Resources Sharing Center

Fight COVID-19 without having to start from scratch

In order to win this battle against COVID-19, we must work together and share our experience around the world. The First Affiliated Hospital, Zhejiang University School of Medicine has treated 104 patients tested positive for COVID-19 in 50 days; and it has achieved zero deaths in patients diagnosed, zero patients misdiagnosed, and zero infections in medical staff. Their experts wrote real treatment experience when combating the virus night and day, and quickly published this Handbook of COVID-19 Prevention and Treatment, in order to share their invaluable practical advice and references with medical professionals around the world. This handbook compares and analyzes the experience of other experts in China; gives detailed and comprehensive answers to potential questions for diagnosing and treating patients in different types; and provides a good reference to key departments such as hospital infection management, nursing, and outpatient clinics. This handbook provides comprehensive guidelines and best practices by China's top experts for coping with COVID-19.

Key contents include:

Technical strategies for prevention and treatment of the epidemic

Treatment methods to treat the critically ill

Nursing methods and experience

This handbook is currently available in Chinese, English, Italian, French, Spanish, Japanese, German, Persian and Bahasa Indonesia and will be translated to Arabic soon. Other language versions contributed by volunteers will also be continuously shared. The Resources Sharing Center will continue to launch more anti-epidemic resources and provide more practical suggestions and references for medical staff worldwide.

Coming soon

العربية

Currently available in English, Chinese, Italiano, Français, Español, 日本語, Deutsch, فارسی, Indonesian Bahasa Indonesia, Coming soon in العربية.

Note: for immediate consultation, you can contact The First Affiliated Hospital, Zhejiang University School of Medicine through the below instruction.

You can download translated versions of Handbook contributed by volunteers.

DISCLAIMER

These are translated versions provided by volunteers. We sincerely thank them for their contributions. We will keep updating and add more language versions as soon as possible.

International Medical Expert Communication Center

Scholars and Heroes: Doctors Fighting Against COVID-19

The International Medical Expert Communication Center has invited many frontline medical staff who have offered medical care for COVID-19 patients in the anti-epidemic battle to share their valuable experience with the world.

This center aims to enable medical workers in different countries and regions to share the latest clinical experience in preventing and controlling COVID-19 in real time, and to fight against COVID-19 in a global and digital way. It supports real-time AI translation in 11 languages including English, Japanese and Spanish, and provides free audio and video teleconferences and live broadcasts for complex scenarios. Medical staffs around the world can communicate with Chinese doctors for one-on-one sharing of their anti-epidemic experience, or participate in live streaming activities hosted by Chinese hospitals and ask questions to Chinese doctors. Hospitals around the world can conduct remote video conferences, experience exchanges, and remote consultations with Chinese hospitals.

Talks by COVID-19 Warriors

Practical Experience Sharing of Medical Experts from the Frontlines
Here's today's top videos. Stay tuned for more future videos.

Hospital Strategies to Prevent and Control COVID-19

The video demonstrates measures SAHZU has taken to manage its patients, protect its medical staff and apply information technology to cope with the outbreak of COVID-19.

Speaker

Jian'an WangPresident of SAHZU, Professor, Chief Physician

Profile: Direct and oversee all COVID-19 affairs at SAHZU; Chair SAHZU COVID-19 Prevention and Control Steering Committee

The First Batch of Hospitals to Join the International Medical Expert Communication Center

The First Affiliated Hospital, Zhejiang University School of Medicine

Experience for Fighting with COVID-19: As the designated hospital for critically ill COVID-19 patients in Zhejiang Province, it has achieved zero infections in medical staff and zero deaths in patients diagnosed. In cooperation with Jack Ma Foundation and Alibaba Foundation, FAHZU released The Handbook of COVID-19 Prevention and Treatment, based on practical experience in fighting against COVID-19, which has been shared to 219 countries and regions.

Hospital Introduction:The First Affiliated Hospital, Zhejiang University School of Medicine (FAHZU), founded in 1947, is one of the first National Medical Centers and National-level Regional Medical Centers of China, with 22 national key specialties including Organ Transplantation, ICU and Infectious Diseases. FAHZU has also organized a team of experts who contributed to the handbook to exchange and cooperate with you on this platform.

Show More
Show Less

The Second Affiliated Hospital Zhejiang University School of Medicine

Experience for Fighting with COVID-19: Since the outbreak of COVID-19, about 180 SAHZU doctors and nurses have been taking care of critical patients at ICU in Wuhan. The infection control expert from SAHZU has contributed to the design of temporary hospitals for COVID-19 patients in Wuhan. SAHZU’s experience in battling the disease was shared with and recognized by leading medical professionals from the United States, the United Kingdom, Ireland, and other countries.

Hospital Introduction: Founded in 1869, the Second Affiliated Hospital Zhejiang University School of Medicine (SAHZU) is a JCI accredited academic medical center with global impact. Renowned for being the origin of western medicine in Zhejiang Province, it was the designated healthcare provider to the G20 Hangzhou Summit and is a magnet for foreign physicians with training programs every year. An experienced and dedicated team is ready to share their experience with you on this platform.

Show More
Show Less

Sir Run Run Shaw Hospital

Experience for Fighting with COVID-19: Since the outbreak of COVID-19, SRRSH has dispatched 189 professional medical staff to Wuhan, Jingmen and other cities for treating critical patients as well as successfully saving the one ICU patient by ECMO, and has put forward the Whole-process Anti-Pandemic System innovatively. Meanwhile, it has also set up online specialist consultation, which is the first in China. Till now, online consultation services for 32,674 patients have been provided.

Hospital Introduction: Sir Run Run Shaw Hospital (SRRSH), affiliated with the Zhejiang University School of Medicine, was managed by Loma Linda University Health in the first five years. It is the only member of Mayo Clinic Care Network in China, and the designated medical institution for the G20 and B20 summits. It has passed both the JCI Accreditation (for 4 consecutive years) and the international medical informatization certification HIMSS7. It is also the only medical institution having passed the Magnet accreditation in China.

Show More
Show Less

Zhejiang Provincial People's Hospital

Experience for Fighting with COVID-19: Since the outbreak, the hospital has successively sent 5 batches of 205 doctors, nurses and logistics personnel to Wuhan, Hubei, to support the front line work, which is the largest number of dispatched medical staff from Zhejiang province. The medical staff of our hospital successively supported several severe hospitals in Wuhan. Among them, the national emergency medical rescue team (Zhejiang province) established many quadrangle Fangcang makeshift hospitals, which contributed a lot to the anti-epidemic work.

Hospital Introduction: Zhejiang Provincial People's Hospital is one of the largest comprehensive tertiary first-class hospitals in Zhejiang province, integrating medical treatment, scientific research, teaching, prevention, health care, and rehabilitation. Since the outbreak, the hospital has successively sent 5 batches of 205 doctors, nurses and logistics personnel to Wuhan, Hubei, to support the front line work, which is the largest number of dispatched medical staff from Zhejiang province. The medical staff of our hospital successively supported several severe hospitals in Wuhan. Among them, the national emergency medical rescue team (Zhejiang province) established many quadrangle Fangcang makeshift hospitals, which contributed a lot to the anti-epidemic work. Our hospital is willing to discuss with you, share valuable experience and overcome difficulties with people all over the world.

Show More
Show Less

Zhongnan Hospital of Wuhan University /Wuhan Leishenshan Hospital

Experience for Fighting with COVID-19: The hospital is the only comprehensive hospital that took over three designated hospitals during the "novel coronavirus" outbreak, of which, Wuhan Leishenshan Hospital, which was taken over on February 8th 2020, was a designated hospital dedicated to patients’ care for those with severe coronaviral pneumonia. Leishenshan Hospital was built by more than 15,000 builders in just over 10 days, with a capacity of 1402 beds in 32 wards.

Hospital Introduction:Founded in 1956, Zhongnan Hospital of Wuhan University is a tertiary hospital and an international research-oriented comprehensive teaching hospital located in Hubei province of China. The hospital emphasizes the core value "patient-centered, endeavor-oriented" as its cultural concept, with the ultimate goal of "guarding people’s health".As a responsible hospital, we are willing to contribute our wisdom to the global battle against the coronavirus pandemic.

Show More
Show Less

Scan QR Code to Consult Now

If you need professional advice on COVID-19 prevention and control, please scan the below QR code to join the International Medical Expert Communication Center and communicate with medical institutions and doctors that have experience fighting the epidemic.

Click to learn how it works>>>

COVID-19 Chinese Consultation Center

Heroic doctors who came back from the front lines are helping Chinese living abroad in the fight against COVID-19

How to stay healthy when abroad is a growing concern amid the recent outbreak. To address the concerns of Chinese nationals worldwide, the Jack Ma Foundation and the Alibaba Foundation have urgently launched this COVID-19 Chinese Consultation Center. Many heroic medical staff that came back from Wuhan and participated in the fight against COVID-19 are now volunteering to provide consultation by answering questions on COVID-19 prevention and treatment to Chinese who are living overseas. Now, many hero doctors from The First Affiliated Hospital, Zhejiang University School of Medicine, The 306th Hospital of People's Liberation Army, and Yichang Central People's Hospital have volunteered to join, providing real-time health consultation for Chinese who are living overseas, and answering questions online. This center also provides information on COVID-19 prevention and real-time epidemic tracking services for fellow overseas Chinese compatriots.

Chinese who are living overseas can go to the Alipay homepage or search for 科学防疫 on Alipay to enter the page to informally consult a doctor.

We would like to sincerely thank the heroes who have just returned from the front lines to be now engaged in this new rescue work! We welcome more doctors to join us to help people around the world to fight against COVID-19.

Start Online Consultation in Just Two Steps
Go to App Store and search Alipay to download Alipay.
Scan to install
Search 科学防疫 to enter this center and consult a doctor.
Go to App Store and search Alipay to download Alipay.
or
Scan to install
Search 科学防疫 to enter this center and consult a doctor.

To Great Doctors, Knights Hospitallers. Calling doctors to volunteer to aid Chinese overseas

(Recruitment conditions: Doctors with frontline experience in the diagnosis and treatment of COVID-19)

Fighting COVID-19 Technology Center

Technology is the best weapon to win the fight against COVID-19.

In the battle against COVID-19, innovative technologies including High Performance Computing (HPC), AI, big data, and cloud computing are indispensable. Fighting COVID-19 Technology Center aims to use the power of advanced technology to support the globe in the fight against COVID-19.

Open Computing Power to Global Public Research Institutions

Fighting COVID-19 Technology Center opens its computing power to global public research institutions for free to accelerate the development of new drugs, and offers AI technology to help medical institutions improve the efficiency of lung CT image analytics and COVID-19 virus screening. The center also provides machine learning and deep learning technology to help policy makers make well-informed decisions through epidemic prediction.

Open Computing Power to Global Public Research Institutions

Fighting COVID-19 Technology Center opens its computing power to global public research institutions for free to accelerate the development of new drugs, and offers AI technology to help medical institutions improve the efficiency of lung CT image analytics and COVID-19 virus screening. The center also provides machine learning and deep learning technology to help policy makers make well-informed decisions through epidemic prediction.

Accelerate Research and Development for COVID-19 Drugs and Vaccine

The development of new drugs and vaccines for COVID-19 requires large amounts of data analysis, as well as large-scale literature screening and scientific computing. HPC and AI technology helps scientific research institutions to perform viral gene sequencing, conduct new drug research and development, and shorten the research and development cycle. The Global Health Drug Discovery Institute (GHDDI) has established a scientific data sharing platform and an AI drug screening platform for COVID-19 with the support of this center's open AI computing power. Some research institutions and universities have increased the speed of biological information transmission by 5 times, and reduced the virtual screening time for antiviral drugs from one month to one week.

Accelerate Research and Development for COVID-19 Drugs and Vaccine

The development of new drugs and vaccines for COVID-19 requires large amounts of data analysis, as well as large-scale literature screening and scientific computing. HPC and AI technology helps scientific research institutions to perform viral gene sequencing, conduct new drug research and development, and shorten the research and development cycle. The Global Health Drug Discovery Institute (GHDDI) has established a scientific data sharing platform and an AI drug screening platform for COVID-19 with the support of this center's open AI computing power. Some research institutions and universities have increased the speed of biological information transmission by 5 times, and reduced the virtual screening time for antiviral drugs from one month to one week.

>

Whole Genome Analysis Improves Efficiency of COVID-19 Virus Screening and Detection

When facing a severe epidemic such as COVID-19, rapid and accurate virus screening and detection is particularly important for maintaining control. The AI algorithm avoids the high missed detection rate of nearly 40% of PCR, and can accurately detect virus mutations and shorten the duration of genetic analysis of suspected cases from hours to just 30 minutes, greatly reducing the time of virus screening and detection.

>

Whole Genome Analysis Improves Efficiency of COVID-19 Virus Screening and Detection

When facing a severe epidemic such as COVID-19, rapid and accurate virus screening and detection is particularly important for maintaining control. The AI algorithm avoids the high missed detection rate of nearly 40% of PCR, and can accurately detect virus mutations and shorten the duration of genetic analysis of suspected cases from hours to just 30 minutes, greatly reducing the time of virus screening and detection.

>

Reduce the Time of CT Image Analytics of COVID-19

On average, a patient with COVID-19 has more than 2,000 CT images during the entire hospitalization process. Manually reading and comparing image data from every patient requires great effort. AI technology can assist realizing quantitative analysis, speeding up CT image analytics, avoiding errors caused by fatigue, and adjusting treatment plans in real time.

Reduce the Time of CT Image Analytics of COVID-19

On average, a patient with COVID-19 has more than 2,000 CT images during the entire hospitalization process. Manually reading and comparing image data from every patient requires great effort. AI technology can assist realizing quantitative analysis, speeding up CT image analytics, avoiding errors caused by fatigue, and adjusting treatment plans in real time.

>

Perform Epidemic Prediction

COVID-19 is a great threat, and policy makers want to understand the impact of different policies on the development of COVID-19, and how long strict control measures should be maintained. AI models can be used to predict the spread of COVID-19 and help decision makers evaluate the impact of various prevention and control measures on the development of the epidemic.

>

Perform Epidemic Prediction

COVID-19 is a great threat, and policy makers want to understand the impact of different policies on the development of COVID-19, and how long strict control measures should be maintained. AI models can be used to predict the spread of COVID-19 and help decision makers evaluate the impact of various prevention and control measures on the development of the epidemic.

>

Join GMCC Today

One World, One Fight!

Initiators and Sponsors

Initiators

Sponsors Members

Supporters

DISCLAIMER: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE

The information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.